Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCL) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous (IV) formulations.
## Primary Indications
* Treatment and prevention of hypokalemia.
* Potassium supplementation in patients receiving diuretics that deplete potassium.
## Adult Dosing
* **Oral:**
* **Prevention:** 20 mEq (1.5 g) daily in 1-2 divided doses.
* **Treatment:** 40-100 mEq (3-7.5 g) daily in 3-5 divided doses.
* **Maximum individual dose:** Generally limited to 20-25 mEq per dose to reduce GI irritation.
* **Intravenous:**
* **Maintenance:** 20-30 mEq (1.5-2.25 g) per 1000 kcal of daily intake.
* **Treatment of hypokalemia:** Dosing is highly individualized based on serum potassium level, severity of symptoms, and patient's renal function. Typical doses range from 10-40 mEq (0.75-3 g) per dose, added to a large volume of IV fluid.
* **Maximum infusion rate:** Peripheral line: 10 mEq/hour (0.75 g/hour). Central line: Up to 20 mEq/hour (1.5 g/hour) may be used cautiously in severe, symptomatic hypokalemia with continuous ECG monitoring. Do not exceed 40 mEq/hour (3 g/hour) in life-threatening situations under strict monitoring.
* **Maximum concentration:** Peripheral line: 40 mEq/L (3 g/L). Central line: Typically up to 80 mEq/L (6 g/L), but higher concentrations may be used cautiously.
## Pediatric Dosing
* **Oral:**
* **Maintenance:** 1-2 mEq/kg/day (0.075-0.15 g/kg/day) divided into 1-2 doses.
* **Maximum daily dose:** Generally not to exceed 3 mEq/kg/day (0.225 g/kg/day).
* **Intravenous:**
* Dosing is highly individualized based on serum potassium level, severity of symptoms, and patient's renal function. Consult pediatric critical care guidelines or specialist recommendations.
* **Maximum infusion rate:** Typically 0.3-0.5 mEq/kg/hour (0.022-0.037 g/kg/hour), not to exceed 10 mEq/hour (0.75 g/hour) for peripheral administration. Higher rates may be used in severe hypokalemia with central line and continuous monitoring.
## Dose Adjustments
* **Renal Impairment:** Dose reductions are necessary. Monitor serum potassium closely. Avoid if hyperkalemia is present.
## Contraindications
* Hyperkalemia.
* Conditions where potassium can accumulate to toxic levels (e.g., untreated Addison's disease, severe renal impairment, anuria, oliguria, certain types of dehydration).
* Use of potassium-sparing diuretics concurrently, unless careful monitoring is in place.
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence.
* **Serious:** Hyperkalemia (muscle weakness, fatigue, paresthesias, arrhythmias, cardiac arrest), esophageal or gastric ulceration/perforation (with oral formulations, especially if not taken with sufficient fluid or in patients with delayed gastric emptying). IV administration can cause phlebitis, pain, and hyperkalemia if infused too rapidly or at too high a concentration.
## Key Drug Interactions
* **ACE inhibitors, ARBs, NSAIDs, potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increase the risk of hyperkalemia.
* **Anticholinergics:** May impair GI motility, potentially increasing the risk of GI irritation with oral potassium.
* **Digoxin:** Hypokalemia enhances digoxin toxicity; potassium repletion can decrease digoxin levels and efficacy. Conversely, hyperkalemia can reduce digoxin's effect.
## Monitoring
* **Serum potassium levels:** Regularly, especially during initiation, dose changes, or in patients with renal impairment or risk factors for hyperkalemia.
* **Renal function (BUN, creatinine):** Assess baseline and periodically.
* **ECG:** Especially in patients receiving IV potassium, those with significant hypokalemia, or risk factors for hyperkalemia.
* **Signs and symptoms of hypokalemia and hyperkalemia.**
* **Fluid and electrolyte balance.**
## Clinical Pearls
* Oral potassium chloride should always be taken with a full glass of water or other fluid to minimize GI irritation.
* Slow-release oral formulations may be better tolerated but can still cause GI issues.
* IV potassium chloride is a vesicant and should be administered with caution, especially at higher concentrations or rates.
* Severe symptomatic hypokalemia may require IV potassium administration at higher rates with continuous monitoring. Local protocols often dictate these specific rates and concentrations.
* Always ensure adequate renal function before administering potassium supplements.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information or a qualified healthcare provider for diagnosis and treatment.